Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (SHE:002864) — Market Cap & Net Worth
Market Cap & Net Worth: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (SHE:002864) has a market capitalization of $319.75 Million (CN¥2.19 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #14616 globally and #4378 in its home market, demonstrating a -2.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's stock price CN¥20.56 by its total outstanding shares 106280960 (106.28 Million). Also see Shaanxi Panlong Pharmaceutical Group Lim balance sheet assets for a full breakdown of the balance sheet.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Market Cap History: 2017 to 2026
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's market capitalization history from 2017 to 2026. Data shows growth from $430.88 Million to $319.75 Million (4.47% CAGR). Also see cash flow conversion of Shaanxi Panlong Pharmaceutical Group Lim for how efficiently the company converts equity into cash flow.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Shaanxi Panlong Pharmaceutical Group Lim (002864) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.42x
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.98x
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's market cap is 4.98 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $430.88 Million | $376.79 Million | $43.72 Million | 1.14x | 9.86x |
| 2018 | $480.70 Million | $489.45 Million | $64.68 Million | 0.98x | 7.43x |
| 2019 | $415.38 Million | $610.64 Million | $71.78 Million | 0.68x | 5.79x |
| 2020 | $381.73 Million | $670.31 Million | $79.12 Million | 0.57x | 4.82x |
| 2021 | $479.10 Million | $887.48 Million | $93.17 Million | 0.54x | 5.14x |
| 2022 | $596.23 Million | $974.29 Million | $101.16 Million | 0.61x | 5.89x |
| 2023 | $594.09 Million | $980.83 Million | $110.43 Million | 0.61x | 5.38x |
| 2024 | $472.94 Million | $973.86 Million | $120.27 Million | 0.49x | 3.93x |
| 2025 | $479.63 Million | $1.14 Billion | $96.28 Million | 0.42x | 4.98x |
Competitor Companies of 002864 by Market Capitalization
Companies near Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A in the global market cap rankings as of September 19, 2026. Review Shaanxi Panlong Pharmaceutical Group Lim tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Historical Marketcap From 2017 to 2026
Between 2017 and today, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's market cap moved from $430.88 Million to $ 319.75 Million, with a yearly change of 4.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥319.75 Million | -33.33% |
| 2025 | CN¥479.63 Million | +1.41% |
| 2024 | CN¥472.94 Million | -20.39% |
| 2023 | CN¥594.09 Million | -0.36% |
| 2022 | CN¥596.23 Million | +24.45% |
| 2021 | CN¥479.10 Million | +25.51% |
| 2020 | CN¥381.73 Million | -8.10% |
| 2019 | CN¥415.38 Million | -13.59% |
| 2018 | CN¥480.70 Million | +11.56% |
| 2017 | CN¥430.88 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $319.75 Million USD |
| MoneyControl | $319.75 Million USD |
| MarketWatch | $319.75 Million USD |
| marketcap.company | $319.75 Million USD |
| Reuters | $319.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chine… Read more